Search Results - "Sikaneta, Tabo"

Vitamin D and Kidney by Tam, Paul, Sahin, Ibrahim, Taskapan, Hulya, Sikaneta, Tabo

“…The receptor has been recognized in a wide variety of tissues such as in osteoblasts, distal renal tubular cells, parathyroid gland cells, skin keratinocytes,…”
Get full text

Risk Factors and Consequences of Hyperaluminemia in a Peritoneal Dialysis Cohort by LAVERGNE, Valery, GHANNOUM, Marc, CHRISTIE, Megan, VO, Van, TAM, Paul W, TING, Robert, SIKANETA, Tabo

“…Widespread Al toxicity is unusual today. In 2005, Canadian peritoneal dialysis (PD) centers reported widespread hyperaluminemia in patients using dialysates…”
Get full text

Hyperaluminemia During Long-term Dialysis: Still Relevant Today by Christie, Megan, BSc, Lavergne, Valery, MD, MSc, Sikaneta, Tabo, MD, Hue, Corinne Seng, PhD, Taskapan, Hulya, MD, Tam, Paul W., MD, Ayoub, Paul, MD, Ting, Robert, MD, Leblanc, Denise, Ghannoum, Marc, MD

Get full text

Adequacy of Dietary Intake of Vitamin D in Stable HD Patients: Are they meeting their needs by Mahdavi, Sara, Amara, Catherine, Sikaneta, Tabo

“…Hypovitaminosis D is associated with reduced survival, increased cardiovascular events, and impaired bone-mineral balance in dialysis. The KDOQI guidelines do…”
Get full text

Polycystin-1 Interacts with Intermediate Filaments by Xu, G. Mark, Sikaneta, Tabo, Sullivan, Brandon M., Zhang, Qunhao, Andreucci, Michele, Stehle, Thilo, Drummond, Iain, Arnaout, M. Amin

“…Polycystin-1, the protein defective in a majority of patients with autosomal dominant polycystic kidney disease, is a ubiquitously expressed multi-span…”
Get full text

Functional patency rates of arteriovenous fistula of a retrospective cohort study from one of the biggest centers in Canada by You, John, Ploszaj, Lilla, Taskapan, Hulya, Sikaneta, Tabo, Ploszaj, Isabella, Joarder, Zahid, Tam, Paul

“…Background The main barriers to arterio-venous fistula (AVF) utilization are primary failure, long maturation duration, and low secondary patency rates…”
Get full text

Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder by Taskapan, Hulya, Mahdavi, Sara, Bellasi, Antonio, Ma, Kuvadia, Saeeda, Patel, Anfal, Taskapan, Berkay, Tarn, Paul, Sikaneta, Tabo

“…Background. Fibroblast growth factor 23 (FGF-23) and other markers of chronic kidney disease--mineral and bone disorder (CKD-MBD) provide valuable insights…”
Get full text

Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder by Taskapan, Hulya, Mahdavi, Sara, Bellasi, Antonio, Martin, Salome, Kuvadia, Saeeda, Patel, Anfal, Taskapan, Berkay, Tam, Paul, Sikaneta, Tabo

“…Fibroblast growth factor 23 (FGF-23) and other markers of chronic kidney disease-mineral and bone disorder (CKD-MBD) provide valuable insights into disease…”
Get full text

Generalized Seizure and Toxic Epidermal Necrolysis Following Levofloxacin Exposure by Christie, Megan J, Wong, Karen, Ting, Robert H, Tam, Paul Y, Sikaneta, Tabo Gordon

“…OBJECTIVE: To report the case of a ciprofloxacin-allergic patient who developed a generalized tonic—clonic seizure and toxic epidermal necrolysis (TEN)…”
Get full text

Associations between echocardiographic findings and prospective changes in residual renal function in patients new to peritoneal dialysis by Mahdavi, Sara, Yared, Kibar, Wu, George, Omar, Billy, Savundra, Dinesh, Nagai, Gordon, Hockmann, Edgar, Svendrovski, Anton, Bellasi, Antonio, Tam, Paul, Sikaneta, Tabo

“…Although echocardiograms are often performed when peritoneal dialysis is started, associations between commonly reported findings and prospective changes in…”
Get full text

QTc Interval Prolongation Is Independently Associated with FGF23 and Predicts Mortality in Predialysis Chronic Kidney Disease by Sikaneta, Tabo, Ho, Natalie, Bellasi, Antonio, Mahdavi, Sara, Taskapan, Hulya, Svendrovski, Anton, Makanjee, Bhavanesh, Roberts, Jason, Wu, George, Nathoo, Bharat, Tam, Paul

“…Abstract Introduction: QTc interval prolongation is increasingly frequent as chronic kidney disease (CKD) advances and predicts death in dialysis. However,…”
Get full text

QTc interval prolongation independently associates with FGF23 and predicts mortality in predialysis CKD by Sikaneta, Tabo, Ho, Natalie, Bellasi, Antonio, Mahdav, Sara, Taskapan, Hulya, Svendrovski, Anton, Makanjee, Bhavanesh, Roberts, Jason, Wu, George, Nathoo, Bharat, Tam, Paul

“…Introduction: QTc interval prolongation is increasingly frequent as CKD advances and predicts death in dialysis. However, predictors and mortality-risk in…”
Get full text

The Trio Trial – a Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function by Sikaneta, Tabo, Wu, George, Abdolell, Mohamed, Ng, Anita, Mahdavi, Sara, Svendrovski, Anton, Tu, Tony, Mercer, Trish, Tong, Matthew, Oreopoulos, Dimitrios, Tam, Paul

“…Background and objective Residual renal function (RRF) correlates with mortality and morbidity rates in patients receiving peritoneal dialysis (PD). We…”
Get full text

Associations of Calcium from Food Sources versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis Patients by Mahdavi, Sara, Bellasi, Antonio, Nagra, Karan, Johnston, Luke, Tam, Paul, Di Iorio, Biagio, Sikaneta, Tabo

“…Background: Dysregulated serum calcium and FGF23 are associated with increased mortality and morbidity rates in patients receiving hemodialysis. Preliminary…”
Get full text

Treatment of a Hemodialysis Patient With Pulmonary Calcification–Associated Progressive Respiratory Failure With Sodium Thiosulfate by Christie, Megan, Roscoe, Janet, Chee, Jung, Inparajah, Miriam, Vaughn-Neil, Ted, Nagai, Gordon, Ng, Paul, Fung, Jason, Ting, Robert, Tam, Paul, Sikaneta, Tabo

Get full text

MgCaCO3 versus CaCO3 in peritoneal dialysis patients--a cross-over pilot trial by Evsanaa, Baigalmaa, Liu, Irene, Aliazardeh, Babak, Mahdavi, Sara, Bajwa, Gursarn, Gula, Jerry, Tam, Michelle, Sze, Elena, Roscoe, Janet M, Tam, Paul Y, Sikaneta, Tabo

“…Despite adverse effects such as constipation, vascular calcification, and hypercalcemia, calcium-based salts are relatively affordable and effective phosphate…”
Get full text

MgCaCO 3 Versus CaCO 3 in Peritoneal Dialysis Patients – a Cross-over Pilot Trial by Evsanaa, Baigalmaa, Liu, Irene, Aliazardeh, Babak, Mahdavi, Sara, Bajwa, Gursarn, Gula, Jerry, Tam, Michelle, Sze, Elena, Roscoe, Janet M., Tam, Paul Y., Sikaneta, Tabo

“…Background Despite adverse effects such as constipation, vascular calcification, and hypercalcemia, calcium-based salts are relatively affordable and effective…”
Get full text

Aluminum toxicokinetics in peritoneal dialysis patients by Seng Yue, Corinne, Christie, Megan, Lavergne, Valery, Sikaneta, Tabo, Taskapan, Hulya, Mardini, Karine, Tam, Paul, Ting, Robert, Ghannoum, Marc

“…Context. Despite the risk of aluminum (Al) toxicity in dialysis patients, little is known about its toxicokinetics (TK) in this population. A national…”
Get full text

Suppression of Human Melanoma Metastasis by the Metastasis Suppressor Gene, BRMS1 by Shevde, Lalita A, Samant, Rajeev S, Goldberg, Steven F, Sikaneta, Tabo, Alessandrini, Alessandro, Donahue, Henry J, Mauger, David T, Welch, Danny R

“…We recently identified a novel metastasis suppressor gene, BRMS1, in breast cancer. Since the BRMS1 gene maps to chromosome 11q13.1-q13.2 and since chromosome…”
Get full text

Variability in CKD stage in outpatients followed in two large renal clinics by Sikaneta, Tabo, Abdolell, Mohamed, Taskapan, Hulya, Roscoe, Janet, Fung, Jason, Nagai, Gordon, Ting, Robert H., Ng, Paul, Wu, George, Oreopoulos, Dimitrios, Tam, Paul Y.

“…Objective Chronic kidney disease (CKD) is staged by glomerular filtration rate (GFR). CKD stages sometimes vary between routine office visits, and it is…”
Get full text